drugset / Trial / NCT00505505

Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy

NCT00505505

Phase 4 Unknown 800 enrolled University of Roma La Sapienza
RandomizedParallel-groupSingle-blindTreatment

Summary

Strict glycemic control improves mortality and morbidity of patients admitted to the postoperative intensive care unit (ICU). The investigators would like to know if this therapy could improve the long term neurologic and cognitive outcomes of patients treated for acute subarachnoid hemorrhage with either a surgical or intravascular approach.

Timeline

Start
2002-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 50 iu Other